Overview
This paper reviews out-of-pocket (OOP) medical expenditure measures collected in the Health and Retirement Study (HRS), an innovative longitudinal study of health, retirement and aging from the Institute for Social Research at the University of Michigan and supported by the National Institute on Aging and the Social Security Administration. The purpose of the HRS is to learn if individuals and families are preparing for the economic and health consequences of aging, and to identify actions, both individual and societal that can promote or threaten health and wellbeing in retirement. The HRS is unique in gathering information on multiple domains, including income and wealth, health, and labor supply, that are important for understanding the decisions that individuals and families make. The study sample is nationally representative of the U.S. population over age 50 and follows individuals and their spouses from the time of their entry into the survey until death.
Medical expenditures are an important cost of poor health. They are not however, the only cost of poor health which may also include the loss of own or spousal earnings or of a change in residence to accommodate poor health. Medical expenditure measures are important for modeling retirement decisions, assessing household income security in retirement and financial preparation for retirement, and predicting the consequences of health care reform, particularly Medicare reform. The HRS measures OOP spending on hospitals, nursing homes, home health care and special facilities, doctor visits, medication, outpatient surgery, and dentistry. The HRS minimizes non-responses by using "randomentry bracketing," an HRS innovation that elicits ranges of values from respondents who would otherwise give no information at all. Categories of OOP spending are queried differently across survey waves. For example, spending on nursing homes is included in spending on hospitals through wave 2000; thereafter, nursing home spending is asked separately.
Despite the comprehensiveness of the HRS, there are always limitations to what can be learned from population interviews. To assess the quality of current HRS measures of OOP spending, we compare various measures of OOP spending across survey waves to the Medical Expenditure Panel Survey (MEPS) and Medicare Current Beneficiary Survey (MCBS), two surveys that expend considerable resources on measuring both OOP spending and total medical expenditures. Such comparisons make it possible to identify potential bias in the HRS data and to improve HRS measures of OOP.
We investigate four categories of spending: total OOP spending, OOP spending on prescription medications, OOP spending on nursing homes, and nondrug/non-nursing home OOP spending. We analyze OOP on nursing homes separately because it is typically covered differently from other spending, and nursing home expenditures are treated differently in many economic models.
Summary of Findings
• Overall the HRS produces useful data on OOP spending. We summarize the strengths and weaknesses of the measures in this section and we provide recommendations in the following section.
• Overall, 21 percent of HRS respondents do not provide an exact (continuous) amount to the value of OOP spending in at least one category of spending. Some categories, such as hospital, nursing homes, and home health care, have a high percentage of non-response among service users (over 30 percent). But most respondents respond to the unfolding brackets; thus complete non-response (no continuous value, no bracket) is below 5 percent for most categories. Nursing home and home health care are the exceptions with complete non-response rates of 12 percent. However, this represents a small number of observations because utilization of these services is low.
• Out-of-pocket spending in the HRS is highly skewed across all spending categories. High values at the 95 th and 99 th percentiles may be due in part to imputation methods or to measurement error, since recall on health care services and spending more generally is subject to error. Non-response and the skewed nature of the distribution call attention to the importance of understanding how imputation method affects estimates.
• HRS has no systematic bias in its estimate of mean OOP expenditures.
Measures of total OOP spending of HRS respondents that are ages 66 and older are remarkably similar to OOP spending reported by respondents in MCBS and MEPS. The HRS reports relatively high values at the 99 th percentile in some years on drug spending. This is not the case in more recent years (2006 and 2008 • Measures of total OOP spending in HRS are comparable to MCBS in part because OOP spending on non-drug and non-nursing home expenses are underestimated relative to MCBS while OOP spending on prescription medications is over-estimated in comparison to MCBS.
• • In 1996, the only wave in which HRS respondents were queried about total medical expenditures, HRS respondents greatly overestimated total medical expenditures compared to MCBS and MEPS. Reports utilizing brackets in the HRS (1998, 2000 and 2002) compare much more favorably with MCBS and MEPS than the continuous reports from wave 1996.
Recommendations
• HRS should pursue linkages with additional data sources, especially for respondents who report very high spending. Linkages could include obvious and readily available data such as Medicare claims. However, not all older Americans have Medicare or Medicare Part D. Pharmacy records and nursing home administrative data could potential provide linkages for a subset of high use populations.
• More granularity could improve response for self-reporting, especially for prescription drugs. For example, subjects could be asked about each prescription medication they take (and asked to retrieve pill bottles prior to the survey). For each medication, they could be asked to save and produce receipts and prescription bags.
• Non-response could be improved by shrinking the recall window, perhaps to 6 months. An exploratory study to assess possible bias associated with the current window would be warranted. A shorter recall period, as well as linkages to other records as discussed above, could reduce high rates of non-response in nursing home and home health care.
• A thorough assessment of the quality of the data in the right tails is warranted, either through a review of billing records or a study utilizing diaries. The linked Medicare/HRS data would enable this kind of assessment, as would links to individual insurers for respondents under age 65.
• If Medicare links were made available in a timely fashion, some HRS questions for respondents over age 65 could be dropped, thus shortening the survey. These respondents could then spend more time on questions related to utilization not always covered by Medicare, such as nursing home and home health care.
• The HRS should consider asking about the use of health savings accounts and health care reimbursement accounts, and consider using these electronic records to track spending.
• The cut-off points in random-entry brackets have not changed over time.
The cut-off points may need to be revisited given general inflation and medical care cost increases.
Details of Data Analysis

HRS Measures of Health Expenditures
Out-Of-Pocket Medical Expenditures. HRS measures OOP spending on hospital, nursing homes, home health care and special facilities, doctor visits, medication, outpatient surgery, and dentist visits. The survey questions on OOP non-drug spending ask about spending since the last interview or over the past two years and take the form: About how much did you pay out-of-pocket for [type of spending] since [previous wave/in the last two years]?
The survey questions on OOP drug spending ask about average monthly spending; for regular users of prescription drugs, the questions take the form: On average, about how much have you paid out-of-pocket per month for these prescriptions since [previous wave/in the last two years]?
Beginning in Table 1 shows the distribution of OOP spending for each category of spending and across survey waves. Questions about OOP spending asked to the birth cohort born 1923 and earlier and surveyed in 1993 and 1995 differed from other waves on recall period and who responded. For this birth cohort and for survey wave 1993, OOP spending was asked for the prior 12 months and only one person in a coupled household was queried -the self-designated 'financial' respondent.
Total Medical Expenditures. After reporting OOP, respondents in 1996 were asked to estimate total medical costs (OOP plus covered expenditures). This is the only wave in which total expenditure amounts were queried. From 1998 to 2002, respondents were directed immediately into unfolding bracket questions to report total medical expenditure; from 2004 forward, respondents were not asked about total medical expenditures. In Section 4 below, we briefly review the HRS data on total medical expenditures and compare them to MCBS and MEPS.
How Health Expenditures Are Measured in the HRS
For each category of OOP expenditure, respondents are directed to provide the amount of OOP spending for the category, and non-responders are directed into unfolding brackets. Table 1 shows the percent non-response for total OOP and for each category of expenditure by wave, and the percent complete non-response, where complete non-response is the percent of respondents who do not report a continuous value or bracketed amount. Non-response on total OOP across survey waves averages 21 percent, ranging from 16 percent to 29 percent. Some categories, such as hospital, nursing home and home health care, have a high percentage of non-response (on average across waves 30, 36 and 34 percent respectively). Fortunately, most respondents respond to the unfolding brackets; thus complete non-response is below 5 percent for most categories with the exception of nursing home and home health care. Complete non-response is about 12 percent for nursing home and home health care. However, because of the low utilization of these services, this represents a small number of observations. Table 1 shows the distribution of OOP spending for years 1995 through 2008 for total OOP and for each category of spending. The data are conditional on utilization. We base our discussion of the distribution using imputed values for non-response from St. Clair et al. (2010) , which describes the imputation methods.
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The skewed nature of OOP spending is well-documented 3 and reflected in Table 1 by high mean-to-median ratios and 95 th (99 th ) to median ratios for all OOP spending and across spending categories (note that the numbers are not CPI adjusted). The high values at the 95 th and 99 th percentiles may be due in part to measurement error: recall on health care services and spending more generally is subject to error. High values may also be due to imputation methods. However, Hurd and Rohwedder (2009) 4 assess imputation as an explanation for extreme values and conclude that "imputation may contribute to the large outliers in spending but they are not primarily responsible for them (pg. Reporting error is particularly problematic when assessing changes in spending over time at the individual level. One option for assessing the extent to which high values are errors is to collect better measures by asking respondents to keep a diary; diaries are still considered the most accurate way to collect expenditure information.
A minor point relates to bracket values. The cut-off points in bracket values have not changed over time and may need to be reassessed in view of inflation and increasing costs of medical care.
HRS Compared with MCBS and MEPS
We compare OOP spending as reported in HRS, MCBS and MEPS. MCBS is a rotating four-year panel survey of individuals enrolled in Medicare Part A, B or both. Reported expenditures on health care may be of higher quality in MCBS than in HRS reports because respondents utilize calendars to record medical events and are asked to save Medicare Explanation of Benefits forms and receipts from insurance companies. They are also asked to save receipts, prescription bags etc. provided by the pharmacy. MEPS has a 2.5 year long overlapping panel design that facilitates continuous estimates throughout the year for the U.S. civilian and non-institutionalized population. MEPS collects data on health status, health care utilization, health care expenditures, payment sources and amounts, and health insurance coverage of individuals and families. It does not include nursing home residents, and sample sizes for middle and older age individuals are small. Like MCBS, it expends considerable resources on the collection of medical expenditure data; thus MEPS data are considered to be high quality.
HRS non-drug OOP spending covers a two-year recall period. We divide by two for an approximate annual amount and use the middle of the two years as the approximate year for comparability to MCBS and MEPS. HRS respondents that regularly use prescription medications report drug OOP on an average monthly basis. Thus, we multiply HRS respondents' amounts by 12 for an approximate annual amount. Figures 2 and 3 show OOP non-drug spending for years 1997 (HRS survey wave 1998 , MCBS 1997 ) and 2006 /2007 (HRS survey wave 2008 and MCBS 2006 . Average non-drug OOP spending in the HRS is slightly lower than reported in MCBS, but average levels are remarkable similar in both data sets through age 80. In both data sets, OOP non-drug spending trends up with age.
Average OOP spending on prescription drugs is about twice as large in HRS than in MCBS at all ages in 1997 (Figure 4) . In 2006/2007 the differences in OOP spending on prescription drugs in HRS and MCBS is smaller ( Figure 5 ). The higher average annual OOP on drugs in the HRS may result from multiplying the respondent's report of monthly OOP in the HRS by 12 to obtain an annual amount.
In both the HRS and MCBS, mean OOP spending on drugs does not vary much with age. In contrast, when we compare OOP spending on drugs in HRS and MEPS for year 2007 (Figure 6) Figure 6 ).
OOP Spending on Nursing Homes. There are few reports of nursing home utilization in the HRS. In 2008, fewer than 3 percent of respondents reported nursing home expenditures. At the 99 th percentile, OOP spending on nursing homes is $17,000 or more (2006 wave), much less than OOP nursing home expenditures at the 99 th percentile of the MCBS in a comparable year ($33,000). Nursing home expenditures are an important part of medical spending for some households, so fewer reports of OOP spending on nursing homes (in terms of percent reporting) and lower levels of reported expenditures in HRS compared with MCBS merit further investigation. 
OOP Spending on Non-Drug and Non-Nursing Home
Services. HRS reports of OOP spending on non-drug, non-nursing home expenditures do not appear to be plagued by particularly high outliers. Mean values in the HRS are lower than in MCBS and so are values at all points in the distribution. Total OOP spending in HRS compared to MCBS compares favorably in part because OOP spending on non-drug and non-nursing home expenses are underestimated relative to MCBS while OOP spending on prescription medications is over-estimated compared with MCBS.
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